Daehan New Pharm rises 10.77% amid vaccine/diagnostic reagent/epidemic prevention (H1N1, AI, etc.) theme uptrend

On the 16th, the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme rose by 3.04% compared to the previous day, showing strength. Among related stocks, Daehan New Pharm, which is attracting attention, surged by 10.77% compared to the previous day. Daehan New Pharm is known as a manufacturer and seller of pharmaceuticals for humans and animals.

[Graph] Major stock price changes in the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Daehan New Pharm’s quant financial score is 34.94 points, with higher stability and profitability scores than the average of other stocks related to the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme, ranking 18th within the theme. This indicates that from a financial perspective, Daehan New Pharm’s ability to respond to changes in the internal and external economic environment and its efficient profit-generating capability are better compared to other stocks within the theme.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.